Bumper Offer - Urjas oil Just @ Rs. 1
Bispec 10 Tablet (30) is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Urinary Incontinence. Other than this, Bispec 10 Tablet (30) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Bispec 10 Tablet (30). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Bispec 10 Tablet (30) can also lead to other problems, which have been listed below. Usually, these side effects of Bispec 10 Tablet (30) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Bispec 10 Tablet (30)'s effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Bispec 10 Tablet (30)'s effects on the liver, heart and kidney, if any, have been listed below.
Bispec 10 Tablet (30) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Bispec 10 Tablet (30) in conditions like Kidney Disease, Liver Disease. The section on Bispec 10 Tablet (30) contraindications lists all such conditions.
Drug interactions for Bispec 10 Tablet (30) have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Bispec 10 Tablet (30) is not safe while driving, and is is not addictive in nature.
Bispec 10 Tablet (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Bispec 10 Tablet (30) is used -
Moderate
Mild
Is the use of Bispec 10 Tablet (30) safe for pregnant women?
Bispec can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Bispec right away. Take your doctor's advice before taking it again.
Is the use of Bispec 10 Tablet (30) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Bispec. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Bispec 10 Tablet (30) on the Kidneys?
Bispec rarely harms the kidneys.
What is the effect of Bispec 10 Tablet (30) on the Liver?
Bispec may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Bispec 10 Tablet (30) on the Heart?
Bispec is rarely harmful for the heart.
Bispec 10 Tablet (30) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Bispec 10 Tablet (30) unless your doctor advises you to do so -
Is this Bispec 10 Tablet (30) habit forming or addictive?
Bispec 10 Tablet (30) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Bispec 10 Tablet (30) as you may feel sleepy.
Is it safe?
Yes, but take Bispec 10 Tablet (30) only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Bispec 10 Tablet (30) for mental disorders.
Interaction between Food and Bispec 10 Tablet (30)
Taking Bispec 10 Tablet (30) with food does not harm your health.
Interaction between Alcohol and Bispec 10 Tablet (30)
Taking Bispec 10 Tablet (30) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151
